Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Bevacizumab × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 49 Ovarian Neoplasms 29 Carcinoma, Hepatocellular 24 Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Fallopian Tube Neoplasms 15 Colonic Neoplasms 10 Breast Neoplasms 9 Uterine Cervical Neoplasms 8 Liver Neoplasms 8 Rectal Neoplasms 7 Lung Neoplasms 7 Glioblastoma 7 Endometrial Neoplasms 7 Brain Neoplasms 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Recurrence 5 Carcinoma, Renal Cell 5 Carcinoma, Ovarian Epithelial 5 Small Cell Lung Carcinoma 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Colorectal Cancer Metastatic 4 Advanced Solid Tumors 4 Squamous Cell Carcinoma of Head and Neck 3 Medulloblastoma 3 Gastrointestinal Neoplasms 3 Digestive System Neoplasms 3 Carcinoma, Pancreatic Ductal 3

Interventions

Cyclophosphamide 38 Rituximab 35 Prednisone 22 Doxorubicin 21 fludarabine 15 Vincristine 15 Specimen Handling 14 Oxaliplatin 14 Magnetic Resonance Spectroscopy 14 Lenalidomide 14 Gemcitabine 14 polatuzumab vedotin 13 CT-P10 11 Etoposide 10 Biopsy 9 fludarabine phosphate 7 deltacortene 7 axicabtagene ciloleucel 7 Leukapheresis 7 Immunotherapy, Adoptive 7 venetoclax 6 prednylidene 6 glofitamab 6 pembrolizumab 5 obinutuzumab 5 ibrutinib 5 acalabrutinib 5 Prednisolone 5 tisagenlecleucel 4 pegfilgrastim 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡